[◀返回](./home.md)

# 新奇感增强

**新奇感增强**被定义为一种对外部环境的特定部分或整体产生的着迷感增加[\[1\]](#cite_note-Hunt1976-1)、敬畏感[\[1\]](#cite_note-Hunt1976-1)[\[2\]](#cite_note-BonnerFriedman2011-2)[\[3\]](#cite_note-GriffithsJohnson2017-3)以及欣赏感[\[3\]](#cite_note-GriffithsJohnson2017-3)[\[4\]](#cite_note-DasBarnwal2016-4)的体验。这可能导致一种常常令人不知所措的印象，即自然的、存在的、日常的事件，甚至是家居用品等平凡概念，现在都变得相当深刻、有趣且充满意义了呢[\[5\]](#cite_note-Bowers1966-5)[\[6\]](#cite_note-BelserAgin-Liebes2017-6)。

这种效应的体验通常会迫使经历者以一种细节程度和强度去承认、思考和欣赏周围的事物，这种程度在每天的清醒状态下是很难达到的哦。通常会用“惊奇感”[\[1\]](#cite_note-Hunt1976-1)[\[3\]](#cite_note-GriffithsJohnson2017-3)或“焕然一新的世界”[\[4\]](#cite_note-DasBarnwal2016-4)这样的短语来描述它。

新奇感增强通常伴随着其他同时发生的效应，如[个人偏见抑制](/药效/个人偏见抑制.md)、[情绪强化](/药效/情绪强化.md)和[灵性增强](/药效/灵性增强.md)，从而进一步强化体验。它最常见于在[中等](/文档/药物剂量分类.md)[剂量](/文档/给药剂量.md)的[迷幻剂](/文档/药物分类/迷幻剂.md)类化合物的影响下诱发，例如[LSD](/药物/LSD.md)、[赛洛西宾](/药物/赛洛西宾蘑菇.md)和[麦斯卡林](/药物/麦斯卡林.md)。然而，在[大麻类](/文档/药物分类/大麻类.md)、[解离剂](/文档/药物分类/解离剂.md)和[共情剂](/文档/药物分类/共情剂.md)的影响下，也可能在较小程度上发生呢。

## 内容

* [1 精神活性物质](#Psychoactive_substances)
* [2 体验报告](#Experience_reports)
* [3 另见](#See_also)
    + [3.1 参考文献](#References)

### 体验报告

在我们的[主观效应索引](/文档/药效/home.md)中，描述此效应的轶事报告包括：

* [报告/psychounautwiki/Experience:_22mg_2C-B_(oral)_/_100ug_1P-LSD_(sublingual)_-_My_first_time_tripping_alone_(2_days_in_a_row)](报告/psychounautwiki/Experience:_22mg_2C-B_(oral)_/_100ug_1P-LSD_(sublingual)_-_My_first_time_tripping_alone_(2_days_in_a_row))
* [报告/psychounautwiki/Experience:_36mg_4-AcO-DiPT_-_Truly,_one_for_the_psychedelic_animals_among_us](报告/psychounautwiki/Experience:_36mg_4-AcO-DiPT_-_Truly,_one_for_the_psychedelic_animals_among_us)
* [报告/psychounautwiki/Experience:_5-EAPB_(60mg)_%2B_2-FMA_(20mg)_%2B_4-AcO-DMT_(10mg)_-_Emotional_catharsis](报告/psychounautwiki/Experience:_5-EAPB_(60mg)_%2B_2-FMA_(20mg)_%2B_4-AcO-DMT_(10mg)_-_Emotional_catharsis)
* [报告/psychounautwiki/Experience:12_mg_AMT_-_Nicely_Surprised](报告/psychounautwiki/Experience:12_mg_AMT_-_Nicely_Surprised)
* [报告/psychounautwiki/Experience:150mg_MDMA_%2B_20mg_2C-B_-_I_designed_it_this_way_myself](报告/psychounautwiki/Experience:150mg_MDMA_%2B_20mg_2C-B_-_I_designed_it_this_way_myself)
* [报告/psychounautwiki/Experience:2_tabs_DOB_-_My_DOB_Nightmare](报告/psychounautwiki/Experience:2_tabs_DOB_-_My_DOB_Nightmare)
* [报告/psychounautwiki/Experience:2.5g_-_Swim%27s_first_mushroom_trip](报告/psychounautwiki/Experience:2.5g_-_Swim%27s_first_mushroom_trip)
* [报告/psychounautwiki/Experience:225ug_-_Sheer_Awe_and_Joy](报告/psychounautwiki/Experience:225ug_-_Sheer_Awe_and_Joy)
* [报告/psychounautwiki/Experience:250mg_MDA_/_250mg_MDMA_-_unnecessarily_large_dosage](报告/psychounautwiki/Experience:250mg_MDA_/_250mg_MDMA_-_unnecessarily_large_dosage)
* [报告/psychounautwiki/Experience:25mg_-_A_labyrinth_of_organs_and_a_storybook_walk](报告/psychounautwiki/Experience:25mg_-_A_labyrinth_of_organs_and_a_storybook_walk)
* [报告/psychounautwiki/Experience:25mg_3-MeO-PCP_-_Enhanced_film_experience](报告/psychounautwiki/Experience:25mg_3-MeO-PCP_-_Enhanced_film_experience)
* [报告/psychounautwiki/Experience:25mg_Deschloroketamine_-_My_first_time_orally_dosing_DCK](报告/psychounautwiki/Experience:25mg_Deschloroketamine_-_My_first_time_orally_dosing_DCK)
* [报告/psychounautwiki/Experience:3_Grams_of_Mushrooms_-_Reset_on_my_Life,_Experiencing_Satori_and_the_Cosmic_Perspective](报告/psychounautwiki/Experience:3_Grams_of_Mushrooms_-_Reset_on_my_Life,_Experiencing_Satori_and_the_Cosmic_Perspective)
* [报告/psychounautwiki/Experience:3.5g_psilocybe_cubensis_-_Relinquishing_of_Material_Chains/Fear_and_Desolation](报告/psychounautwiki/Experience:3.5g_psilocybe_cubensis_-_Relinquishing_of_Material_Chains/Fear_and_Desolation)
* [报告/psychounautwiki/Experience:300ug_LSD_-_Profound_religious_experience](报告/psychounautwiki/Experience:300ug_LSD_-_Profound_religious_experience)
* [报告/psychounautwiki/Experience:300%C2%B5g_LSD_-_Togetherness_and_the_Silent_Dusk](报告/psychounautwiki/Experience:300%C2%B5g_LSD_-_Togetherness_and_the_Silent_Dusk)
* [报告/psychounautwiki/Experience:337mg_DMT_fumarate_-_A_Day_With_DMT](报告/psychounautwiki/Experience:337mg_DMT_fumarate_-_A_Day_With_DMT)
* [报告/psychounautwiki/Experience:4.5g_-_The_Grand_Introduction_to_Beauty_and_Fear](报告/psychounautwiki/Experience:4.5g_-_The_Grand_Introduction_to_Beauty_and_Fear)
* [报告/psychounautwiki/Experience:40mg_-_Brothermind_and_the_Forest%27s_Hand](报告/psychounautwiki/Experience:40mg_-_Brothermind_and_the_Forest%27s_Hand)
* [报告/psychounautwiki/Experience:4x_200ug_tabs_-_You_do_not_need_to_understand](报告/psychounautwiki/Experience:4x_200ug_tabs_-_You_do_not_need_to_understand)
* [报告/psychounautwiki/Experience:6g_mimosa_/_2.5_g_syrian_rue_-_Best_cake_I%27ve_had_for_a_while](报告/psychounautwiki/Experience:6g_mimosa_/_2.5_g_syrian_rue_-_Best_cake_I%27ve_had_for_a_while)
* [报告/psychounautwiki/Experience:70mg_Lisdexamfetamine_(oral)_-_My_first_stimulant_experience](报告/psychounautwiki/Experience:70mg_Lisdexamfetamine_(oral)_-_My_first_stimulant_experience)
* [报告/psychounautwiki/Experience:750mg_-_Experiencing_Void;_Dissociation_Of_Reality_And_Self](报告/psychounautwiki/Experience:750mg_-_Experiencing_Void;_Dissociation_Of_Reality_And_Self)
* [报告/psychounautwiki/Experience:800ug_LSD_-_3D_Vision](报告/psychounautwiki/Experience:800ug_LSD_-_3D_Vision)
* [报告/psychounautwiki/Experience:DMT_(~50mg)_%2B_Cannabis_-_Geometric_Angels](报告/psychounautwiki/Experience:DMT_(~50mg)_%2B_Cannabis_-_Geometric_Angels)
* [报告/psychounautwiki/Experience:LSD_(150%C2%B5g)_%2B_Cannabis_-_150%C2%B5g_lsd_and_a_shitload_of_weed](报告/psychounautwiki/Experience:LSD_(150%C2%B5g)_%2B_Cannabis_-_150%C2%B5g_lsd_and_a_shitload_of_weed)
* [报告/psychounautwiki/Experience:LSD_(400ug,_Oral)_-_An_afternoon_in_%22a%22_garden](报告/psychounautwiki/Experience:LSD_(400ug,_Oral)_-_An_afternoon_in_%22a%22_garden)
* [报告/psychounautwiki/Experience:LSD_(~500%CE%BCg,_sublingual)_%2B_Noopept_-_Mind_Reset](报告/psychounautwiki/Experience:LSD_(~500%CE%BCg,_sublingual)_%2B_Noopept_-_Mind_Reset)
* [报告/psychounautwiki/Experience:Mushrooms_(~0.5_g)_-_Autonomous_Voice](报告/psychounautwiki/Experience:Mushrooms_(~0.5_g)_-_Autonomous_Voice)
* [报告/psychounautwiki/Experience:Mushrooms_and_Snuff_Films_--_Trip_Report_(3.5_grams)](报告/psychounautwiki/Experience:Mushrooms_and_Snuff_Films_--_Trip_Report_(3.5_grams))
* [报告/psychounautwiki/Experience:Nutmeg_(8_teaspoons)_-_My_Mom_Introduces_Me_To_Genesis_and_Other_Things](报告/psychounautwiki/Experience:Nutmeg_(8_teaspoons)_-_My_Mom_Introduces_Me_To_Genesis_and_Other_Things)
* [报告/psychounautwiki/Experience:Psilocybin_Mushroom_(0.16_g,_Oral)_-_Dosage_Independent_Intensity](报告/psychounautwiki/Experience:Psilocybin_Mushroom_(0.16_g,_Oral)_-_Dosage_Independent_Intensity)


### 另见

* [负责任的用药](/文档/负责任的用药索引页.md)
* [主观效应索引](/文档/药效/home.md)
* [迷幻剂 - 主观效应](/文档/药物分类/迷幻剂.md#Subjective_effects)
* [解离剂 - 主观效应](/文档/药物分类/解离剂.md#Subjective_effects)
* [谵妄剂 - 主观效应](/文档/药物分类/谵妄剂.md#Subjective_effects)


#### 参考文献

1. ↑ [1.0](#cite_ref-Hunt1976_1-0) [1.1](#cite_ref-Hunt1976_1-1) [1.2](#cite_ref-Hunt1976_1-2) Hunt, Harry T. (1976). "A Test of the Psychedelic Model of Altered States of Consciousness". *Archives of General Psychiatry*. **33** (7): 867. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1001/archpsyc.1976.01770070097012](//doi.org/10.1001%2Farchpsyc.1976.01770070097012). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0003-990X](//www.worldcat.org/issn/0003-990X).
2. [↑](#cite_ref-BonnerFriedman2011_2-0) Bonner, Edward T.; Friedman, Harris L. (2011). "A conceptual clarification of the experience of awe: An interpretative phenomenological analysis". *The Humanistic Psychologist*. **39** (3): 222–235. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1080/08873267.2011.593372](//doi.org/10.1080%2F08873267.2011.593372). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [1547-3333](//www.worldcat.org/issn/1547-3333).
3. ↑ [3.0](#cite_ref-GriffithsJohnson2017_3-0) [3.1](#cite_ref-GriffithsJohnson2017_3-1) [3.2](#cite_ref-GriffithsJohnson2017_3-2) Griffiths, Roland R; Johnson, Matthew W; Richards, William A; Richards, Brian D; Jesse, Robert; MacLean, Katherine A; Barrett, Frederick S; Cosimano, Mary P; Klinedinst, Maggie A (2017). "Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors". *Journal of Psychopharmacology*. **32** (1): 49–69. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1177/0269881117731279](//doi.org/10.1177%2F0269881117731279). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0269-8811](//www.worldcat.org/issn/0269-8811).
4. ↑ [4.0](#cite_ref-DasBarnwal2016_4-0) [4.1](#cite_ref-DasBarnwal2016_4-1) Das, Saibal; Barnwal, Preeti; Ramasamy, Anand; Sen, Sumalya; Mondal, Somnath (2016). "Lysergic acid diethylamide: a drug of 'use'?". *Therapeutic Advances in Psychopharmacology*. **6** (3): 214–228. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1177/2045125316640440](//doi.org/10.1177%2F2045125316640440). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [2045-1253](//www.worldcat.org/issn/2045-1253).
5. [↑](#cite_ref-Bowers1966_5-0) Bowers, Malcolm B. (1966). ""Psychedelic" Experiences in Acute Psychoses". *Archives of General Psychiatry*. **15** (3): 240. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1001/archpsyc.1966.01730150016003](//doi.org/10.1001%2Farchpsyc.1966.01730150016003). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0003-990X](//www.worldcat.org/issn/0003-990X).
6. [↑](#cite_ref-BelserAgin-Liebes2017_6-0) Belser, Alexander B.; Agin-Liebes, Gabrielle; Swift, T. Cody; Terrana, Sara; Devenot, Neşe; Friedman, Harris L.; Guss, Jeffrey; Bossis, Anthony; Ross, Stephen (2017). "Patient Experiences of Psilocybin-Assisted Psychotherapy: An Interpretative Phenomenological Analysis". *Journal of Humanistic Psychology*. **57** (4): 354–388. [doi](http://en.wikipedia.org/wiki/Digital_object_identifier "wikipedia:Digital object identifier"):[10.1177/0022167817706884](//doi.org/10.1177%2F0022167817706884). [ISSN](http://en.wikipedia.org/wiki/International_Standard_Serial_Number "wikipedia:International Standard Serial Number") [0022-1678](//www.worldcat.org/issn/0022-1678).
